Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

VEGF gene transfer evaluated for diabetic neuropathy in NIH-funded trial

Dec. 16, 2002

Safety restrictions announced for Eprex/Erypo in patients with chronic renal failure

Dec. 16, 2002

Fujisawa and Daiso present novel compounds with apo B secretion-inhibitory activity

Dec. 16, 2002

Significant improvement reported on eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Dec. 13, 2002

Amended phase II protocol for FM-VP4

Dec. 13, 2002

CTCE-0021 rapidly mobilizes PMNs and hematopoietic progenitor cells

Dec. 12, 2002

Phase I testing of Abiogen's OGP drug to begin in Italy

Dec. 12, 2002

Tetracyclic MCH receptor modulators identified by Tularik scientists

Dec. 12, 2002

Novel alphav integrin antagonists and their use in osteoporosis

Dec. 12, 2002

Neurogen synthesizes GLP-1 receptor modulators with utility in diabetes and eating disorders

Dec. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...